We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Probe Detects Breast Cancer Margins

By HospiMedica International staff writers
Posted on 03 Jul 2012
A new device uses radiofrequency (RF) spectroscopy to differentiate tissue types, helping surgeons assure that all cancerous tissue is removed around a breast cancer site. More...


The MarginProbe system enables real time detection of cancer at or near the surface of excised tissue specimens during surgery for breast cancer. The device works by emitting an RF electric field and sensing the returning signal from the tissue under evaluation. The device is based on the fact that tumors exhibit greater vascularization, a different polarization of the cell membrane, enlarged nucleus volume, rapid copying of DNA, rapid growth of new blood vessels (angiogenesis), and a decrease in the connectivity from one cell to another.

Since these and other and other anatomical differences are evident when compared to healthy tissue, the electromagnetic signature is different as well. The device captures these minute differences in electromagnetic properties via a disposable probe unit that houses a highly responsive fringe field sensor (FFS) that both emits the precisely controlled electromagnetic field and captures the tissue response. The surgeon runs a series of measurements on each margin, collecting data for the entire specimen.

An external console houses proprietary software that captures the signal, compares it to the internal database, and characterizes the specimen, reporting results on the high-resolution display. The display lists each reading sequentially, which allows for grouping measurements from the same margin. The simple and immediate assessment of the surgical margins allows surgeons to immediately excise additional tissue, significantly reducing the potential for positive margins remaining after the initial lumpectomy. The MarginProbe System is a product of Dune Medical (Framingham, MA, USA), and is pending approval by the US food and Drug Administration (FDA).

“We believe that the MarginProbe System will give surgeons a powerful tool in their fight against breast cancer and provide women a substantially better chance of avoiding additional surgeries,” said Dan Levangie, CEO of Dune Medical. “We will work closely with the FDA to complete the approval process and intend to launch the MarginProbe System in the U.S. immediately thereafter.”

RF Spectroscopy is concerned with the measurement of the intervals between atomic or molecular energy levels that are separated by radio frequency wavelengths. It is used in such industries as the semiconductor, pharmaceutical, aerospace, and fuel cell fields.

Related Links:
Dune Medical


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.